Dr. Hughes at University of Missouri-St. Louis uses TruSeq Targeted RNA Expression to uncover the genetic mechanisms of circadian rhythms.Learn More
Frank Middleton, Ph.D., at SUNY-UMU developed a focused gene panel to screen for expression alterations caused by a newly discovered CNV in schizophrenia using the MiSeq System.Learn More
Figure 3 from TruSeq Targeted RNA Expression Data Sheet, August 2013
With TruSeq RNA Expression, run 500 targets on 48 samples in one run in less than two days, compared to 63 runs in ~16 days with qPCR methods.
TruSeq Targeted RNA Expression fixed panels (including neurodegeneration, p53, apoptosis, stem cells, and others) have been discontinued. We recommend using TruSeq Targeted RNA Expression custom panels as a replacement. Illumina remains committed to providing you with high-quality support and service.